Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Feb 18 04:00PM ET
83.29
Dollar change
+0.28
Percentage change
0.34
%
IndexDJIA, S&P 500 P/E12.37 EPS (ttm)6.73 Insider Own0.12% Shs Outstand2.53B Perf Week-3.60%
Market Cap210.69B Forward P/E8.42 EPS next Y9.89 Insider Trans0.31% Shs Float2.53B Perf Month-17.29%
Income17.12B PEG1.00 EPS next Q2.13 Inst Own79.48% Short Float1.17% Perf Quarter-15.44%
Sales64.30B P/S3.28 EPS this Y17.88% Inst Trans-0.15% Short Ratio2.13 Perf Half Y-26.49%
Book/sh17.58 P/B4.74 EPS next Y9.70% ROA10.83% Short Interest29.60M Perf Year-33.80%
Cash/sh5.79 P/C14.40 EPS next 5Y12.39% ROE28.33% 52W Range82.09 - 134.63 Perf YTD-16.27%
Dividend Est.3.26 (3.91%) P/FCF14.20 EPS past 5Y12.04% ROI21.54% 52W High-38.13% Beta0.35
Dividend TTM3.12 (3.75%) Quick Ratio1.15 Sales past 5Y7.21% Gross Margin80.65% 52W Low1.46% ATR (14)2.29
Dividend Ex-DateMar 17, 2025 Current Ratio1.36 EPS Y/Y TTM163.70% Oper. Margin33.71% RSI (14)22.60 Volatility2.16% 2.23%
Employees72000 Debt/Eq0.86 Sales Y/Y TTM7.41% Profit Margin26.62% Recom1.85 Target Price115.75
Option/ShortYes / Yes LT Debt/Eq0.79 EPS Q/Q404.83% Payout46.32% Rel Volume1.89 Prev Close83.01
Sales Surprise0.91% EPS Surprise6.88% Sales Q/Q9.93% EarningsFeb 04 BMO Avg Volume13.87M Price83.29
SMA20-9.49% SMA50-14.06% SMA200-25.79% Trades Volume25,897,772 Change0.34%
Date Action Analyst Rating Change Price Target Change
Feb-18-25Downgrade Deutsche Bank Buy → Hold $128 → $105
Feb-10-25Downgrade TD Cowen Buy → Hold $121 → $100
Jan-08-25Downgrade Truist Buy → Hold $110
Dec-20-24Downgrade BMO Capital Markets Outperform → Market Perform $136 → $105
Dec-10-24Resumed BofA Securities Buy $121
Dec-04-24Upgrade HSBC Securities Hold → Buy $130
Nov-15-24Initiated Wolfe Research Peer Perform
Nov-11-24Downgrade Daiwa Securities Buy → Neutral
Oct-17-24Initiated Bernstein Mkt Perform $115
Mar-11-24Downgrade Societe Generale Hold → Sell $104
Feb-18-25 03:55PM
01:27PM
12:00PM
06:56AM
06:45AM
05:45AM Loading…
05:45AM
Feb-16-25 08:57PM
Feb-15-25 01:30PM
Feb-13-25 03:54PM
09:00AM
07:13AM
Feb-12-25 09:00PM
01:27PM
Feb-11-25 10:42AM
07:00AM
02:27AM Loading…
02:27AM
Feb-10-25 06:02PM
09:04AM
Feb-09-25 03:03PM
Feb-08-25 05:34AM
Feb-06-25 06:45AM
05:07AM
Feb-05-25 05:10PM
01:25PM
08:45AM
08:06AM
07:00AM
06:39AM
02:08AM
01:31AM
04:14PM Loading…
Feb-04-25 04:14PM
03:15PM
03:01PM
02:38PM
12:40PM
12:36PM
12:28PM
10:47AM
10:38AM
09:17AM
08:34AM
08:21AM
08:21AM
07:07AM
07:00AM
06:54AM
06:37AM
06:30AM
06:30AM
Feb-03-25 11:28AM
Feb-02-25 04:13PM
07:00AM
Feb-01-25 04:44PM
Jan-31-25 10:50AM
06:49AM
06:45AM
Jan-30-25 12:45PM
09:00AM
06:45AM
Jan-29-25 04:24PM
08:04AM
08:00AM
06:58AM
Jan-28-25 01:28PM
01:22PM
10:00AM
Jan-27-25 03:07PM
06:45AM
Jan-25-25 01:18PM
10:58AM
Jan-24-25 07:12AM
06:45AM
06:17AM
Jan-22-25 07:10PM
04:46PM
04:34PM
01:59PM
Jan-20-25 12:00PM
07:37AM
Jan-19-25 06:15PM
Jan-18-25 05:08PM
12:31PM
08:20AM
Jan-17-25 04:13PM
09:46AM
09:00AM
Jan-16-25 06:45AM
Jan-15-25 12:37PM
Jan-14-25 03:26PM
01:04PM
08:43AM
01:35AM
Jan-13-25 12:10PM
10:57AM
Jan-10-25 04:56PM
02:12PM
Jan-08-25 06:48AM
Jan-07-25 01:36AM
Jan-06-25 06:45AM
Jan-02-25 11:15AM
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DAVID WILLIAMSOfficerFeb 13 '25Proposed Sale85.346,000512,057Feb 13 04:10 PM
Williams David MichaelEVP,Chief Info&Digital OfficerFeb 13 '25Sale85.346,000512,05724,123Feb 13 04:01 PM
Oosthuizen Johannes JacobusPresident, U.S. MarketFeb 08 '25Option Exercise87.2813,0021,134,81545,609Feb 11 02:59 PM
THULIN INGE GDirectorFeb 06 '25Buy88.252,833250,0002,933Feb 07 04:09 PM
Downing Cristal NChief Comm. & Public Afrs OfcrFeb 06 '25Sale88.762,361209,5517,085Feb 07 04:07 PM
BAKER DOUGLAS M JRDirectorFeb 05 '25Buy88.5015,0001,327,50016,000Feb 07 04:04 PM
CRISTAL DOWNINGOfficerFeb 06 '25Proposed Sale88.762,361209,551Feb 06 04:43 PM
Guindo ChirfiChief Marketing OfficerAug 05 '24Option Exercise115.2036,9014,250,99557,782Aug 06 12:20 PM
Smart DaltonSVP Fin. - Global ControllerMay 03 '24Option Exercise128.262,046262,4204,708May 06 04:10 PM
Smart DaltonSVP Fin. - Global ControllerMay 04 '24Option Exercise127.5161278,0364,730May 06 04:10 PM
DeLuca Richard R.EVP&Pres, Merck Animal HeallthMay 04 '24Option Exercise127.5127,1263,458,836163,720May 06 04:08 PM
Klobuchar Michael AEVP - Chief Strategy OfficerMay 04 '24Option Exercise127.51887113,10124,058May 06 04:06 PM
Oosthuizen Johannes JacobusPresident, U.S. MarketMay 04 '24Option Exercise127.51912116,28924,271May 06 04:01 PM
Romanelli JosephPresident, Human Health Int?lMay 02 '24Option Exercise128.802,262291,34621,831May 02 04:29 PM
Smart DaltonSVP Fin. - Global ControllerMay 02 '24Option Exercise128.8038149,0733,048May 02 04:23 PM
Merck & Co., Inc.10% OwnerMar 11 '24Buy23.0021,397,205492,135,7151,000Mar 11 03:27 PM